Search
Gallopamil
go.drugbank.com/drugs/DB12923InvestigationalGallopamil has been used in trials studying the treatment of Asthma.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesGET-73
go.drugbank.com/drugs/DB12928InvestigationalGet 73 has been investigated for the treatment of Alcohol Dependence.
Phloroglucinol
go.drugbank.com/drugs/DB12944InvestigationalPhloroglucinol has been used in trials studying the diagnostic of Colonoscopy.
Categories: Compounds used in a research, industrial, or household setting2,2-bis(4-hydroxy-3-tert-butylphenyl)propane
go.drugbank.com/drugs/DB13008InvestigationalTBD has been used in trials studying the treatment of Adenocarcinoma.
Synonyms: 2,2-bis(4-hydroxy-3-tert-butylphenyl)propanePentavalent Antimony
go.drugbank.com/drugs/DB13047InvestigationalPentavalent Antimony has been investigated for the treatment of Cutaneous Leishmaniasis.
Synonyms: Antimony cation (5+)Clorobiocin
go.drugbank.com/drugs/DB03966ExperimentalClorobiocin is an aminocoumarin antibiotic, similar to [novobiocin] and coumermycin A1.
Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingApc001
go.drugbank.com/drugs/DB17819ExperimentalApc001 is an aptamer developed for the treatment of osteogenesis imperfecta.
Prulifloxacin
go.drugbank.com/drugs/DB11892InvestigationalPrulifloxacin has been investigated for the treatment of Urinary Tract Infection.
Categories: 4-Quinolones, Heterocyclic Compounds, 1-RingSisomicin
go.drugbank.com/drugs/DB12604InvestigationalSisomicin has been used in trials studying the treatment of Pyoderma.
Synonyms: (2S-CIS)-4-O-(3-AMINO-6-(AMINOMETHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL)-2-DEOXY-6-O-(3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA.-L-ARABINOPYRANOSYL)-D-STREPTAMINE, O-3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA-L-ARABINOPYRANOSYL-(1->4)-O-(2,6-DIAMINO-2,3,4,6-TETRADEOXY-.ALPHA.-D-GLYCERO-HEX-4-ENOPYRANOSYL-(1->6))-2-DEOXY-L-STREPTAMINECategories: Drugs that are Mainly Renally Excreted with a Narrow Therapeutic IndexAd5-nCoV
go.drugbank.com/drugs/DB15655InvestigationalThe study will evaluate antibody response in healthy patients between the ages of 18 and 60 who will receive one of three study doses, with follow-up taking place at weeks 2 and 4 and months 3 and 6 post-vaccination … [L12675,L12678] It is being developed by CanSino Biologics Inc., in partnership with the Beijing Institute of Biotechnology, who in March 2020 announced the approval of a phase I clinical trial (ChiCTR2000030906
Synonyms: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)